9711525

Source:http://linkedlifedata.com/resource/pubmed/id/9711525

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0220650, umls-concept:C0684249
pubmed:issue	2
pubmed:dateCreated	1998-11-17
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8800805
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0169-5002
pubmed:author	pubmed-author:EllisRR, pubmed-author:GregorAA
pubmed:issnType	Print
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	81-4
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:9711525-Antineoplastic Agents, pubmed-meshheading:9711525-Brain Neoplasms, pubmed-meshheading:9711525-Clinical Trials as Topic, pubmed-meshheading:9711525-Combined Modality Therapy, pubmed-meshheading:9711525-Dose Fractionation, pubmed-meshheading:9711525-Humans, pubmed-meshheading:9711525-Lung Neoplasms, pubmed-meshheading:9711525-Palliative Care, pubmed-meshheading:9711525-Quality of Life, pubmed-meshheading:9711525-Survival Analysis
pubmed:year	1998
pubmed:articleTitle	The treatment of brain metastases from lung cancer.
pubmed:affiliation	Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland, UK.
pubmed:publicationType	Journal Article